Valve-in-Valve TAVR for Degenerated Perceval Valves Authors: Mouna Kodali, Rajesh Gutpa, Ahmad Mahdi, Omar Sajdeya, Ashish Yadav, George V Moukarbel Published: 2026 ABSTRACT AbstractBackgroundValve-in-valve transcatheter aortic valve replacement (ViV-TAVR) is an established treatment option for bioprosthetic valve failure. The sutureless Perceval bioprosthesis presents unique technical challenges because of the valve's supra-annular nitinol ring, lack of radiopaque markers, and potential difficulty with central valve crossing and entrapment of devices within the supra-annular ring.Case SummaryWe report 2 cases of Perceval degeneration managed with ViV-TAVR using balloon-expandable Edwards Sapien 3 Ultra valves. In the first case, standard retrograde crossing led to delivery system entrapment despite multiple conventional methods for assessing central crossing, requiring multiple complex bailout maneuvers including balloon-assisted displacement and TAVR delivery system snaring. In the second case, after failed central retrograde crossing, antegrade transseptal approach with arteriovenous loop formation enabled precise central crossing. After wire externalization via the femoral artery, standard retrograde TAVR delivery and successful valve deployment were performed without complication. Both patients experienced favorable outcome and symptom resolution at follow-up.Take-Home MessagesThese cases highlight the importance of preprocedural planning, advanced imaging guidance, and alternative access and crossing strategies when performing ViV-TAVR in Perceval valves. The antegrade approach may be safer, is reproducible, and saves on procedure time.Key words: aortic valve, aortic valve replacement, imaging, intravascular ultrasound, X-ray fluoroscopy The Perceval Sutureless Valve's Supra-Annular Nitinol Frame and Lack of Radiopaque Markers Predispose to Noncentral Wire Crossing During Retrograde ViV-TAVR, Increasing the Risk of Delivery System Entrapment An alternative anterograde transseptal approach along with IVUS and TEE guidance enables controlled central crossing, facilitating precise valve delivery and successful deployment with favorable outcomes. IVUS = intravascular ultrasound; LV = left ventricle; RA = right atrium; RV = right ventricle; TEE = transesophageal echocardiography; ViV = valve-in-valve; TAVR = valve-in-valve transcatheter aortic valve replacement. Valve-in-valve transcatheter aortic valve replacement (ViV-TAVR) has emerged as a preferred alternative to redo surgical intervention in high-risk patients with structural degeneration of bioprosthetic valves.1, 2, 3, 4 The Perceval sutureless surgical valve (Corcym) was designed to reduce operative time and improve hemodynamics in surgical aortic valve replacement (Figure 1A).5 However, our cases demonstrate that it poses unique challenges for ViV-TAVR. Its self-expanding supra-annular nitinol frame and ring, which lack radiopaque markers, can hinder coaxial alignment and complicate valve crossing. Furthermore, the supra-annular ring often lacks apposition to the aortic wall. All of these factors lead to high risk of noncentral crossing, device entrapment, or underexpansion.6 Take-Home Messages •This series highlights the difficulty of central valve crossing in Perceval ViV-TAVR and encourages early confirmation of central wire position using multimodality imaging (TEE, IVUS, fluoroscopy) before advancing the delivery system. This series highlights the difficulty of central valve crossing in Perceval ViV-TAVR and encourages early confirmation of central wire position using multimodality imaging (TEE, IVUS, fluoroscopy) before advancing the delivery system. •In challenging anatomy, consider an antegrade transseptal approach early in the algorithm, as it can facilitate controlled central crossing, improve procedural efficiency, and reduce the risk for complications. In challenging anatomy, consider an antegrade transseptal approach early in the algorithm, as it can facilitate controlled central crossing, improve procedural efficiency, and reduce the risk for complications. Perceval Bioprosthetic Valve (A) The Perceval sutureless aortic bioprosthetic valve. (B and C) Preprocedural computed tomography angiography demonstrating lack of coaptation between the edge of the supra-annular ring of the Perceval valve and the aorta in patient 1 (B) and patient 2 (C). The red arrows point to the distances. We present 2 cases of ViV-TAVR in patients with degenerated Perceval bioprostheses, both considered prohibitive surgical candidates. In the first case, traditional retrograde valve crossing resulted in delivery system entrapment, requiring multiple complex bailout maneuvers for successful TAVR delivery system and balloon removal. In contrast, the second case used an alternative antegrade transseptal approach that allowed for precise central valve crossing under transesophageal echocardiographic and intravascular ultrasound guidance, leading to a more straightforward deployment without entrapment or other complications. Patient 1 A 76-year-old man with prior surgical aortic valve replacement using a bioprosthetic Perceval valve in 2019 presented with NYHA functional class IV symptoms due to severe aortic regurgitation from leaflet prolapse. He was evaluated by the cardiothoracic surgery team and was found to have a Society of Thoracic Surgeons (STS) predicted risk of mortality of 5.06% and risk of mortality and morbidity of 29.2%. The patient was deemed inoperable by the heart team given multiple comorbidities, frailty, and 2 prior sternotomies. Preprocedural transesophageal echocardiography (TEE) confirmed bioprosthetic valve degeneration with severe aortic regurgitation and a preserved ejection fraction of 55%. Computed tomography (CT) angiography demonstrated a prosthetic aortic valve 23 mm in diameter. CT angiography data were consistent with a favorable anatomy for ViV-TAVR, with low coronary obstruction risk. We proceeded with a transfemoral ViV-TAVR with a 26-mm balloon-expandable Edwards Sapien 3 Ultra valve. Care was taken to confirm crossing of the superior Perceval valve ring in a central position, using multiple catheters and rotating the catheters while crossing and confirming central crossing on multiple fluoroscopic views (Figures 2A and 2B). The Sapien valve was then able to be delivered relatively easily to the target position (Figure 2C). After successful valve deployment under rapid pacing, it was not possible to retract the delivery balloon, which was entrapped in the Perceval frame, likely because of crossing outside the central axis of the supra-annular nitinol ring (Figure 2D). We pulled on the delivery balloon while trying to advance the wire slightly forward, with no success. During these maneuvers, the whole valve system would move with the delivery system as a unit, and the patient would feel chest pain, limiting the ability to pull harder. Multiple bailout strategies, including applying additional negative suction on the balloon, parallel wire access, and balloon-assisted displacement, failed. Emergency surgery was entertained, but ultimately, we snared the TAVR delivery catheter and balloon from within the left ventricle to apply forward traction on the TAVR delivery system, which allowed changing the trajectory of the delivery system in order to achieve successful extraction of the TAVR delivery system and balloon (Figure 2E). Coronary Angiogram Images of Valve Deployment, Entrapment, and Snaring in Patient 1 (A) Coronary angiography demonstrating crossing the valve with the wire. (B) Central crossing of the Perceval valve ring was confirmed using multiple fluoroscopic views. (C) This was followed by deployment of the Edwards Sapien valve. (D) The balloon delivery system was entrapped behind the Perceval frame, and partial inflation attempt to release the balloon was unsuccessful. (E and F) The system was successfully retrieved after snaring. Postdeployment imaging showed trivial paravalvular leak and no evidence of aortic injury. Echocardiography revealed acute decline in left ventricular ejection fraction to 15%, likely related to the significant stress to the heart from a prolonged procedure and significant mechanical traction while attempting removal of the entrapped system. The ejection fraction improved to 50% after completion of cardiac rehabilitation. The patient remained asymptomatic at follow-up. Patient 2 An 83-year-old man who had undergone surgical aortic valve replacement in 2017 with a bioprosthetic Large Perceval was admitted for systolic congestive heart failure because of degeneration and stenosis of the bioprosthetic aortic valve. TEE confirmed severe aortic prosthesis stenosis. Pre-TAVR CT demonstrated a surgically placed Perceval valve with an embedded geometry suggesting a 26-mm diameter. The pre-TAVR CT also showed favorable anatomy. The patient was evaluated by the cardiothoracic surgery team and was deemed to be at high risk for redo aortic valve replacement given STS predicted risk of mortality of 14% and risk of mortality and morbidity of 32.6%. We proceeded with TAVR under general anesthesia via transfemoral access and TEE guidance. Attempts at retrograde crossing of the degenerated surgical Perceval valve were unsuccessful despite multiple catheter strategies and intravascular ultrasound (IVUS) guidance, as the wire repeatedly passed outside the supra-annular nitinol ring (Figure 3A). After multiple failed retrograde attempts, we decided to change strategy and proceed with an antegrade transseptal approach. Using standard femoral venous access, transseptal puncture was performed under TEE guidance. A Glidewire (Terumo) was then manipulated through the mitral valve and out of the left ventricular outflow tract and through the Perceval device, ensuring central crossing (Figure 3B). The wire was then snared in the thoracic aorta with the snare advanced from femoral artery sheath (Figure 3C). After the wire was externalized from the femoral artery sheath, an arteriovenous loop was created. We then advanced a pigtail catheter over the arteriovenous loop starting at the femoral arterial access. Once the pigtail catheter was in the left ventricular cavity, the Glidewire was then removed, leaving the pigtail catheter free in the left ventricle (Figure 3D). This technique facilitated central valve crossing, confirmed by TEE and IVUS (Figure 3E). A 26-mm Edwards Sapien 3 Ultra Resilia valve was deployed in the standard retrograde fashion after being advanced from the femoral arterial sheath and after balloon aortic valvuloplasty. Postdeployment balloon dilation was performed given mild underexpansion. Final hemodynamic and echocardiographic assessment showed a mean transvalvular gradient of 3 mm Hg and no paravalvular leak or pericardial effusion. The patient remained hemodynamically stable throughout and tolerated the procedure without complications. Coronary Angiography of Successful Central Crossing Using Multiple Techniques in Patient 2 (A) Intravascular ultrasound was used to guide central crossing. (B) The anterograde transseptal approach was used to cross the wire from the left ventricle to the aorta using transesophageal echocardiography guidance. (C and D) The wire was snared in the aorta, an arteriovenous loop was created, and a pigtail catheter was advanced in the left ventricle to ensure central crossing. (E) The valve was successfully deployed. Post-TAVR transthoracic echocardiography confirmed the TAVR valve was well seated in the aortic position with normal Doppler flows and a mean gradient of 6 mm Hg. There was no prosthesis regurgitation. At the 1-month follow up, the patient's symptoms had completely resolved, and he was in good clinical condition. Transthoracic echocardiography showed a mean gradient of 5 mm Hg, with no paravalvular leak or pericardial effusion. Discussion ViV-TAVR in patients with prior Perceval bioprostheses presents distinct procedural challenges that differ from those encountered with other conventional surgical valves.6, 7, 8 The Perceval valve, a self-expanding, sutureless bioprosthesis composed of a nitinol stent frame with supra-annular ring, lacks radiopaque markers and has a unique design that may complicate central valve crossing given lack of aortic apposition with the supra-annular ring.8 These anatomic characteristics increase the risk of delivery system malalignment and, as demonstrated in our first case, entrapment of the TAVR delivery system and balloon within the Perceval valve frame. The first case underscores the potential technical pitfalls associated with standard retrograde valve wire crossing from the aorta in Perceval valves. Despite the use of multiple fluoroscopic views and catheter configurations, retrograde passage failed to achieve central valve crossing, resulting in TAVR delivery system and balloon entrapment. Ultimately, successful retrieval required a combination of balloon-assisted displacement, parallel wire access, and wire snaring techniques, highlighting the importance of readiness for bailout strategies when performing ViV-TAVR in challenging anatomy. In contrast, the second case illustrates the effectiveness of a transseptal antegrade crossing approach with adjunctive imaging, including TEE and IVUS. This method allowed precise traversal of the surgical valve under direct imaging guidance. The formation of an arteriovenous rail enabled stable, central valve crossing, resulting in successful retrograde TAVR delivery and deployment with minimal hemodynamic compromise. This strategy proved more efficient and is easily reproducible, avoiding the complications seen in the first case. Interestingly, the antegrade transseptal approach was used in the first human TAVR procedure performed by Dr Alain Cribier in 2002.9 A novel catheter called the “EasyCross” has been developed to ensure central valve crossing for ViV-TAVR and was found to show 100% technical success in a small, single-center randomized study.10 The additional use of this catheter could provide promising procedural success, but larger randomized studies are needed to confirm this. The cases presented here emphasize the value of meticulous preprocedural planning and the use of advanced imaging tools to guide strategy selection. They also suggest that for patients with Perceval valves and difficult anatomy, antegrade wire crossing should be considered earlier in the procedural algorithm to minimize complications and procedural time. Ultimately, both patients experienced favorable clinical outcomes with resolution of symptoms and preserved valve function at follow-up. Conclusions ViV-TAVR in Perceval sutureless valves is technically challenging, primarily because of difficulty achieving central valve crossing through the supra-annular nitinol frame. This anatomic limitation increases the risk of perivalvular passage and device entrapment. Our experience demonstrates that an antegrade transseptal approach guided by TEE and IVUS facilitates precise central crossing and offers a safer, more reproducible alternative to conventional retrograde valve-crossing techniques. Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose. Footnotes The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center. Appendix For supplemental videos, please see the online version of this paper. Appendix Video 1 Entrapped Delivery Balloon in the Perceval Frame, Retrieved by Snaring the Delivery Catheter From Within the Left Ventricle Video 2 Successful Central Crossing of the Balloon Delivery System, Guided by IVUS, TEE, and Anterograde Transeptal Approach References Associated Data Supplementary Materials Video 1 Entrapped Delivery Balloon in the Perceval Frame, Retrieved by Snaring the Delivery Catheter From Within the Left Ventricle Video 2 Successful Central Crossing of the Balloon Delivery System, Guided by IVUS, TEE, and Anterograde Transeptal Approach